I would personally temper my expectations here a little on near term profitability.
Do we know which form of profitability that the company is referring to? I prefer NPAT because it is what is available to shareholders. Companies however typically prefer EBITDA because it is easier to generate.
EBITDA breakeven is possible on a monthly basis towards the end of the calendar year but NPAT breakeven looks like it is futher six months away to me and will require maybe up to $35m of revenue to achieve.
If I had to guess I would say we are probably looking at a $3-4m NPAT loss in the second half of FY24, versus a $5.6m loss in the first half.
The good news for the patient is that if/when it becomes apparent that NPAT profitability is guaranteed then I think we can see the big re-rate from 2x sales to 5x sales.
I would personally temper my expectations here a little on near...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $60.63M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 27.0¢ | 25.0¢ | $76.52K | 294.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 152928 | 3 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.5¢ |
Change
0.005 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 26.5¢ | 25.5¢ | 74924 | ||
| Last updated 15.07pm 13/05/2024 ? | |||||
| EYE (ASX) Chart |